Literature DB >> 22807449

The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding.

Jessica Hartmann1, Thuy-Van Tran, Janina Kaudeer, Karin Oberle, Julia Herrmann, Isabell Quagliano, Tobias Abel, André Cohnen, Volker Gatterdam, Andrea Jacobs, Bernd Wollscheid, Robert Tampé, Carsten Watzl, Andreas Diefenbach, Joachim Koch.   

Abstract

The natural cytotoxicity receptors are a unique set of activating proteins expressed mainly on the surface of natural killer (NK) cells. The human natural cytotoxicity receptor family comprises the three type I membrane proteins NKp30, NKp44, and NKp46. Especially NKp30 is critical for the cytotoxicity of NK cells against different targets including tumor, virus-infected, and immature dendritic cells. Although the crystal structure of NKp30 was recently solved (Li, Y., Wang, Q., and Mariuzza, R. A. (2011) J. Exp. Med. 208, 703-714; Joyce, M. G., Tran, P., Zhuravleva, M. A., Jaw, J., Colonna, M., and Sun, P. D. (2011) Proc. Natl. Acad. Sci. U.S.A. 108, 6223-6228), a key question, how NKp30 recognizes several non-related ligands, remains unclear. Therefore, we investigated the parameters that impact ligand recognition of NKp30. Based on various NKp30-hIgG1-Fc fusion proteins, which were optimized for minimal background binding to cellular Fcγ receptors, we identified the flexible stalk region of NKp30 as an important but so far neglected module for ligand recognition and related signaling of the corresponding full-length receptor proteins. Moreover, we found that the ectodomain of NKp30 is N-linked glycosylated at three different sites. Mutational analyses revealed differential binding affinities and signaling capacities of mono-, di-, or triglycosylated NKp30, suggesting that the degree of glycosylation could provide a switch to modulate the ligand binding properties of NKp30 and NK cell cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22807449      PMCID: PMC3438985          DOI: 10.1074/jbc.M111.304238

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity.

Authors:  O Mandelboim; P Malik; D M Davis; C H Jo; J E Boyson; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

2.  Expression of natural cytotoxicity receptors NKp30, NKp44, and NKp46 mRNAs and proteins by human hematopoietic and non-hematopoietic cells.

Authors:  Bejai I S Srivastava; Maya D Srivastava
Journal:  Leuk Res       Date:  2005-08-02       Impact factor: 3.156

3.  IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice.

Authors:  X X Zheng; A W Steele; W W Hancock; K Kawamoto; X C Li; P W Nickerson; Y Li; Y Tian; T B Strom
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

4.  NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor.

Authors:  Massimo Vitale; Mariella Della Chiesa; Simona Carlomagno; Daniela Pende; Maurizio Aricò; Lorenzo Moretta; Alessandro Moretta
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

5.  Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Authors:  Tal I Arnon; Hagit Achdout; Ofer Levi; Gal Markel; Nivin Saleh; Gil Katz; Roi Gazit; Tsufit Gonen-Gross; Jacob Hanna; Efrat Nahari; Angel Porgador; Alik Honigman; Bodo Plachter; Dror Mevorach; Dana G Wolf; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2005-04-10       Impact factor: 25.606

6.  Evidence that the cellular ligand for the human NK cell activation receptor NKp30 is not a heparan sulfate glycosaminoglycan.

Authors:  Hilary S Warren; Allison L Jones; Craig Freeman; Jayaram Bettadapura; Christopher R Parish
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

7.  NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.

Authors:  Monia Draghi; Achal Pashine; Bharati Sanjanwala; Ketevan Gendzekhadze; Claudia Cantoni; David Cosman; Alessandro Moretta; Nicholas M Valiante; Peter Parham
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

8.  Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool.

Authors:  Oren Hershkovitz; Mostafa Jarahian; Alon Zilka; Ahuva Bar-Ilan; Guy Landau; Sergey Jivov; Yoram Tekoah; Rachel Glicklis; John T Gallagher; Sabrina C Hoffmann; Hagit Zer; Ofer Mandelboim; Carsten Watzl; Frank Momburg; Angel Porgador
Journal:  Glycobiology       Date:  2007-11-15       Impact factor: 4.313

9.  Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity.

Authors:  A Pessino; S Sivori; C Bottino; A Malaspina; L Morelli; L Moretta; R Biassoni; A Moretta
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

10.  Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44.

Authors:  Andreina Byrd; Sabrina C Hoffmann; Mostafa Jarahian; Frank Momburg; Carsten Watzl
Journal:  PLoS One       Date:  2007-12-19       Impact factor: 3.240

View more
  21 in total

1.  The Activating C-type Lectin-like Receptor NKp65 Signals through a Hemi-immunoreceptor Tyrosine-based Activation Motif (hemITAM) and Spleen Tyrosine Kinase (Syk).

Authors:  Björn Bauer; Tanja Wotapek; Tobias Zöller; Emilia Rutkowski; Alexander Steinle
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

2.  Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.

Authors:  Julia Herrmann; Hannah Berberich; Jessica Hartmann; Steffen Beyer; Karen Davies; Joachim Koch
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

3.  Reconstitution of a ligand-binding competent murine NKp30 receptor.

Authors:  Stefanie Memmer; Sandra Weil; Joachim Koch
Journal:  Immunogenetics       Date:  2017-08-07       Impact factor: 2.846

4.  The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3ζ Complex.

Authors:  Stefanie Memmer; Sandra Weil; Steffen Beyer; Tobias Zöller; Eike Peters; Jessica Hartmann; Alexander Steinle; Joachim Koch
Journal:  J Biol Chem       Date:  2016-10-17       Impact factor: 5.157

5.  Galectin-9 functionally impairs natural killer cells in humans and mice.

Authors:  Lucy Golden-Mason; Rachel H McMahan; Michael Strong; Richard Reisdorph; Spencer Mahaffey; Brent E Palmer; Linling Cheng; Caroline Kulesza; Mitsuomi Hirashima; Toshiro Niki; Hugo R Rosen
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

6.  The identification of additional zebrafish DICP genes reveals haplotype variation and linkage to MHC class I genes.

Authors:  Ivan Rodriguez-Nunez; Dustin J Wcisel; Ronda T Litman; Gary W Litman; Jeffrey A Yoder
Journal:  Immunogenetics       Date:  2016-01-22       Impact factor: 2.846

7.  Targeting of a natural killer cell receptor family by a viral immunoevasin.

Authors:  Richard Berry; Natasha Ng; Philippa M Saunders; Julian P Vivian; Jie Lin; Felix A Deuss; Alexandra J Corbett; Catherine A Forbes; Jacqueline M Widjaja; Lucy C Sullivan; Adrian D McAlister; Matthew A Perugini; Melissa J Call; Anthony A Scalzo; Mariapia A Degli-Esposti; Jerome D Coudert; Travis Beddoe; Andrew G Brooks; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2013-05-12       Impact factor: 25.606

8.  Immunohistochemical detection of angiotensin II receptors in mouse cerebellum and adrenal gland using "in vivo cryotechnique".

Authors:  Zheng Huang; Nobuhiko Ohno; Nobuo Terada; Yurika Saitoh; Jiaorong Chen; Shinichi Ohno
Journal:  Histochem Cell Biol       Date:  2013-03-21       Impact factor: 4.304

9.  A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cells.

Authors:  Janina Binici; Jessica Hartmann; Julia Herrmann; Christine Schreiber; Steffen Beyer; Günnur Güler; Vitali Vogel; Franz Tumulka; Rupert Abele; Werner Mäntele; Joachim Koch
Journal:  J Biol Chem       Date:  2013-10-16       Impact factor: 5.157

Review 10.  Glycosylation of Immune Receptors in Cancer.

Authors:  Ruoxuan Sun; Alyssa Min Jung Kim; Seung-Oe Lim
Journal:  Cells       Date:  2021-05-04       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.